new antiepileptic, Gabitril (tiagabine)

    Abbott is introducing a new antiepileptic, Gabitril (tiagabine). It's coming out now in the U.S...next year in Canada.

    Gabitril will be used as add-on therapy for partial seizures.

    It's thought to work by blocking the reuptake of GABA...the major inhibitory neurotransmitter in the CNS. The increased GABA levels "apply the brakes" to inhibit seizures.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote